Skip to content

A study for comparing of pain relief after surgery in children using either dexmedetomidine with ropivacaine or tramadol with ropivacaine for lower body operation

Comparison of analgesic efficacy of caudal Dexmedetomidine versus caudal Tramadol with Ropivacaine in paediatric infraumblical surgeries: A Prospective randomised study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090175
Enrollment
34
Registered
2025-07-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Injection Ropivacaine 0.75 percentage injection Dexmedetomidine 2mcg per kg Injection Tramadol 2mg per kg: With due approval from institutional ethical committee a prospective Randomise

Sponsors

J L N Medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 and 2 undergoing elective infraumblical surgeries

Exclusion criteria

Exclusion criteria: Patient refusal patient having history or evidence of infection at the back, allergy to drugs ,bleeding /coagulation disorder history of developmental delay sepsis

Design outcomes

Primary

MeasureTime frame
Duration of analgesiaTimepoint: assessment of visual analogue for pain in post operative period at immediately after shifting post operative unit after 1hr,2hr, 3hr, 4hr, 6hr, 8hr, 10hr

Secondary

MeasureTime frame
the duration of motor block, post operativeTimepoint: 5-point sedation score emergence time. FLACC pain score with its 0-10 score range each patient pain intensity will assessed 1hr 2hr 3hr 4hr 5hr 6hr,every 3hr till 12hr

Countries

India

Contacts

Public ContactDR MAINA SINGH

Jawahar Lal Nehru Medical College Ajmer Rajasthan

mainasingh111@gmail.com9414097045

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026